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Background. Approximately 6% of children hospitalized with severe falciparum malaria in Africa are also bacteremic. It is 
therefore recommended that all children with severe malaria should receive broad-spectrum antibiotics in addition to parenteral 
artesunate. Empirical antibiotics are not recommended currently for adults with severe malaria.
Methods. Blood cultures were performed on sequential prospectively studied adult patients with strictly defined severe falcip-
arum malaria admitted to a single referral center in Vietnam between 1991 and 2003.
Results. In 845 Vietnamese adults with severe falciparum malaria admission blood cultures were positive in 9 (1.07%: 95% 
confidence interval [CI], .37–1.76%); Staphylococcus aureus in 2, Streptococcus pyogenes in 1, Salmonella Typhi in 3, Non-typhoid 
Salmonella in 1, Klebsiella pneumoniae in 1, and Haemophilus influenzae type b in 1. Bacteremic patients presented usually with 
a combination of jaundice, acute renal failure, and high malaria parasitemia. Four bacteremic patients died compared with 108 
(12.9%) of 836 nonbacteremic severe malaria patients (risk ratio, 3.44; 95% CI, 1.62–7.29). In patients with >20% parasitemia the 
prevalence of concomitant bacteremia was 5.2% (4/76; 95% CI, .2–10.3%) compared with 0.65% (5/769; 0.08–1.2%) in patients 
with <20% parasitemia, a risk ratio of 8.1 (2.2–29.5).
Conclusions. In contrast to children, the prevalence of concomitant bacteremia in adults with severe malaria is low. 
Administration of empirical antibiotics, in addition to artesunate, is warranted in the small subgroup of patients with very high 
parasitemias, emphasizing the importance of quantitative blood smear microscopy assessment, but it is not indicated in most adults 
with severe falciparum malaria.
Keywords.  Plasmodium falciparum; malaria; severe malaria; bacteremia.
Malaria is associated with bacterial infection, but the relation-
ship is complex [1]. In endemic areas, where the majority of 
symptomatic malaria occurs in children (ie, areas of moderate 
or high transmission), malaria is associated with an increased 
risk of bacteremia [2–9]. This risk is greatest in severe falcip-
arum malaria. In a meta-analysis of 7208 children with severe 
malaria, included in 25 studies across 11 African countries, 
the mean prevalence of invasive bacterial infections was esti-
mated to be 6.4% (95% confidence interval [CI], 5.81–6.98%) 
[8]. In these malaria-endemic areas it is now generally accepted 
that children presenting with severe malaria should receive 
broad-spectrum antibiotics in addition to parenteral artesunate 
[1, 10], as concomitant bacteremia cannot be excluded, and it 
is difficult to distinguish clinically between severe malaria and 
sepsis [11, 12]. A  severely ill febrile child with a low parasit-
emia could have severe malaria or sepsis with incidental par-
asitemia. In contrast, in prospective studies of severe malaria 
conducted in low-transmission settings, where the majority of 
patients are adults, concomitant malaria and sepsis have been 
reported rarely—although there are few incidence data [13, 
14]. Currently, empirical antibiotic treatment is not recom-
mended in adults with severe malaria [1, 10]. However, 2 recent 
overlapping studies from Myanmar have challenged this recom-
mendation. These studies found that 13 of 87 (15%) adult pa-
tients hospitalized with a diagnosis of malaria were bacteremic 
(ie, a substantially higher proportion than in African children 
with severe malaria) [15, 16]. Their report concluded that “clin-
icians should have a lower threshold for commencing empirical 
antibacterial therapy in adults diagnosed with falciparum ma-
laria in these locations than is presently recommended.” Clearly, 
this is an important issue. We report a very large prospectively 
studied series of Vietnamese adults with strictly defined severe 
D
ow
nloaded from
 https://academ
ic.oup.com
/cid/advance-article-abstract/doi/10.1093/cid/ciaa191/5763096 by guest on 09 M
ay 2020
2 • cid 2020:XX (XX XXXX) • Phu et al
falciparum malaria in whom blood cultures were taken routinely 
in all patients on admission to the specialist treatment ward.
METHODS
This investigation took place in the severe malaria ward of the 
Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam, 
during 2 sequential studies of adult patients admitted with 
strictly defined severe falciparum malaria. The first, conducted 
between 1991 and 1996, was a double-blind comparison of in-
tramuscular quinine and intramuscular artemether [17], and the 
second, conducted between 1996 and 2003, was a double-blind 
comparison of intramuscular artesunate and intramuscular 
artemether [18]. These 2 studies, reported previously in detail, 
were contiguous and all eligible patients were enrolled. Both 
studies were approved by the Ethical and Scientific Committee 
of the Hospital for Tropical Diseases, Ho Chi Minh City.
Entry Criteria
Patients were included in the studies if they (or an accom-
panying relative) gave informed consent, they had asexual 
forms of Plasmodium falciparum on a peripheral-blood smear, 
were older than 14  years, were not in the first trimester of 
pregnancy, were not intravenous drug users, had received 
less than 3 g of quinine or 2 doses of artemisinin or a deriv-
ative in the previous 48 hours, were not allergic to the study 
drugs, and had 1 or more of the following: Glasgow Coma Scale 
score less than 11 (indicating cerebral malaria), anemia (he-
matocrit, <20%) with a parasite density greater than 100 000/
μL, jaundice (serum total bilirubin, >2.5 mg/dL [50 µmol/L]) 
with a parasite density greater than 100  000/μL, acute kidney 
injury (urine output, <400  mL/24 hours, and serum creati-
nine, >3 mg/dL [250 µmol/L]), hypoglycemia (blood glucose, 
<40  mg/dL [2.2  mmol/L]), more than 10% parasitemia, and 
systolic blood pressure less than 80 mm Hg with cool extrem-
ities (indicating shock). These criteria are similar to the World 
Health Organization–endorsed definition [1], except that the 
anemia criterion is more stringent.
Clinical Management and Procedures
On enrollment, patients were examined and weighed and base-
line blood samples were taken for full blood count, clotting 
studies, biochemistry, arterial pH and blood gases, blood cul-
tures, and thin- and thick-film malaria parasite counts. A full 
history was taken from the patient or attendant relatives and a 
full clinical examination performed including a detailed neuro-
logic assessment. A urinary catheter was inserted. Patients were 
managed by a dedicated team according to standard recom-
mendations [1]. Antimalarial treatment was started immedi-
ately with either artesunate, artemether, or quinine according 
to randomization as described previously [17, 18]. All patients 
were given isotonic saline initially, and fluid balance was then 
maintained with 0.9% saline or 5% dextrose in water. When 
necessary, a central venous catheter was inserted and the cen-
tral venous pressure maintained at 5  cm of water. Blood was 
transfused if the hematocrit fell below 20%. Hypoglycemia 
was corrected with an injection of 50 mL of 30% dextrose and 
a subsequent maintenance infusion of 5% to 10% dextrose in 
water. Detailed clinical and nursing observations were recorded 
a minimum of every 4 hours for the first 24 hours. A diagnostic 
lumbar puncture was performed if the Glasgow Coma Scale 
score was below 14. Hemofiltration was started in patients with 
established renal failure. Patients with respiratory failure were 
ventilated. Acetaminophen was given for high fever (>39°C), 
and intravenous diazepam, intramuscular phenobarbital, and 
if necessary, intravenous phenytoin were given for convulsions. 
Antibiotics with no clinical antimalarial activity (ie, usually 
cefotaxime 2 mg/kg every 6 hours or ceftriaxone 2 g daily but 
not tetracyclines, macrolides, trimethoprim–sulfamethoxazole, 
or chloramphenicol) were given only if indicated clinically or 
cultures were positive, and confirmed enteric fever was treated 
with ofloxacin, but antibiotics were not started routinely.
Microbiology
Between 5 and 15  mL of blood was taken for blood cultures 
(target, 10 mL). Between 1991 and 1997 a manual blood cul-
ture system was used [18]. Each 5-mL venous blood aliquot 
was inoculated into 50 mL of brain heart infusion broth (Tissue 
Culture Services, Perth,  UK) with 0.05% sodium polyanethol 
sulfonate (Sigma, St Louis, MO). Blood culture bottles were 
vented and incubated at 35–37oC for 7 days. Blind subculture 
was performed at 24 and 48 hours and at 7 days or whenever 
physical growth was observed in the bottles. In September 1997, 
a BACTEC (Becton-Dickinson, Singapore) culture system was 
introduced. Aliquots of blood (5–8  mL) were inoculated into 
BACTEC plus aerobic bottles and then incubated for 5 days in a 
BACTEC 9050 automated analyzer. Bottles that gave a positive 
signal were subcultured.
Subcultures were plated onto fresh sheep blood agar and 
heated blood (chocolate) agar if Haemophilus influenzae or 
Neisseria meningitidis was suspected, and onto Sabouraud’s agar 
if a yeast or mold was suspected (all media supplied by Oxoid 
Unipath, Basingstoke, UK). Plates were incubated at 37oC in air 
(blood agar) or 5% CO2 (chocolate agar) for 48 hours or 30
oC 
in air (Sabouraud’s agar) for 5 days. Organisms were identified 
by standard methods including API identification kits (Bio-
Mérieux, Basingstoke, UK) when necessary. Specific antisera 
were used to identify Salmonella serogroups, including Vi for 
Salmonella enterica serovar Typhi (S. Typhi). Staphylococcus 
epidermidis, or other skin commensals were considered 
contaminants.
Statistical Methods
Proportions were compared using Fisher’s exact test using 
Epiinfo (CDC, Atlanta, Georgia).
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RESULTS
Blood culture results were available for 845 adult patients ad-
mitted with severe falciparum malaria. Of these, 9 were positive 
for pathogens, a prevalence of 1.07% (95% CI, .37–1.76%). The 
organisms cultured were S. Typhi [3], non-typhoid Salmonella 
[1], Staphylococcus aureus [2], Group A  Streptococcus [1], 
H. influenzae type b [1], and Klebsiella pneumoniae [1] (Table 1). 
An additional patient’s blood grew Burkholderia  cepacia, but 
this was regarded as a contaminant, and the patient recovered 
uneventfully without receiving antibacterial treatment. The 
usual clinical presentation in these bacteremic patients was with 
the hepatorenal syndrome of fever, jaundice, and acute kidney 
injury accompanied by high parasitemia. One patient was un-
conscious (cerebral malaria).
Fatal Cases
Four of the 9 patients with severe malaria and concomitant bac-
teremia died, as discussed in the following:
 1. A 47-year-old male farmer admitted with 20.1% parasitemia, 
jaundice, and shock died 2.5 hours after admission. Blood 
cultures subsequently grew Staphylococcus aureus.
 2. A 24-year-old male farmer with a 7-day history of fever had 
generalized convulsions followed by coma on the day of ad-
mission. His parasitemia was 0.9%. He had clinical signs of 
pneumonia, for which he was given ceftriaxone, but he died 
29 hours later without regaining consciousness. Blood cul-
tures subsequently grew S. Typhi.
 3. A 28-year-old male soldier with a 5-day history of fever was 
admitted with 24.9% parasitemia, jaundice, and acute renal 
failure. He died 16 hours later. Blood cultures subsequently 
grew H. influenzae type b.
 4. A 48-year-old male builder with a 6-day history of fever 
presented with 24.6% parasitemia, hyperlactatemia, acute 
oliguric kidney injury, jaundice, pulmonary edema, and 
upper gastrointestinal bleeding. Hemofiltration was started 
immediately. His parasitemia rose to 54% within 8 hours 
of admission. He received artemether and, because sepsis 
was suspected clinically, he was given ceftriaxone. On day 
2, blood cultures grew K.  pneumoniae, and amikacin was 
added. After a protracted course he developed nosocomial 
pneumonia and he died 24 days later.
The overall mortality of patients with severe malaria but no con-
comitant bacteremia was significantly lower, 12.9% (108/836). 
The risk ratio for death in patients with concomitant bacte-
remia was 3.44 (95% CI, 1.62–7.29; P = .022).
Risk Factors
The 9 patients admitted with severe malaria and concom-
itant bacteremia were slightly older (median age, 47  years; 
range, 17–60  years) than the other 836 patients (median age, Ta
bl
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31  years; range, 15–79  years). They were also more likely to 
be hyperparasitemic; the median (range) parasite count was 
501 144/μL (39 564 to 1 765 936/μL) compared with 81 766/
μL (12 811 to 316 512/μL) in the patients with nonbacteremic 
severe malaria. Four of the 9 bacteremic patients had more 
than 20% parasitemia compared with 72 of 836 nonbacteremic 
patients (risk ratio, 5.16; 95% CI, 2.41–11.07; P = .0054). Thus, 
the prevalence of concomitant bacteremia in patients with more 
than 20% parasitemia was 5.2% (4/76; 95% CI, .2–10.3%) 
compared with 0.65% (5/769; .08–1.2%) in patients with less 
than 20% parasitemia, a risk ratio of 8.1 (95% CI, 2.2–29.5). 
Mortality in nonbacteremic patients with more than 20% para-
sitemia was 18% (13 of 72). Leukocytosis, which may also occur 
in very severe malaria infections, and other hematological or 
biochemical indices were not useful as indicators of concomi-
tant bacteremia. Only 1 of the 8 bacteremic patients with a dif-
ferential white blood cell count performed on admission had a 
neutrophilia.
Community-acquired Bacteremias
Between 1991 and 2000, during which 90% of the patients in 
this series were recruited, S. Typhi was the predominant path-
ogen recovered from blood cultures taken in the hospital [18], 
comprising 41% (91/219) of isolates in 1991 and 25% (85/334) 
in 2000. Corresponding proportions for S.  aureus were 14% 
(31/219) in 1991 and 10% (33/334) in 2000.
DISCUSSION
In this large prospective study of Vietnamese adults admitted to 
the hospital with strictly defined severe falciparum malaria the 
rate of concomitant bacteremia was low. This contrasts with large 
studies in African children with severe malaria in whom con-
comitant bacteremia is sufficiently common (more than 5 times 
more common than in adults in this series) [8], and the clinical 
distinction between severe malaria and sepsis is sufficiently dif-
ficult [11, 12] to warrant administration of antibiotics on admis-
sion to all children with a diagnosis of severe malaria [1, 10]. This 
low rate of concomitant bacteremia in adults supports current 
recommendations that empiric antibiotics should not be given 
on admission to adults with severe malaria unless there is clear 
evidence of a bacterial infection [1, 10]. The important excep-
tion is patients with very high parasite densities (>20% parasit-
emia) who were 5.2 (95% CI, 2.4–11.1) times more likely to be 
bacteremic. These high parasite counts in bacteremic patients, 
particularly the fatal cases, suggest that disease severity resulted 
primarily from malaria illness. The increased risk of bacteremia 
with very high parasitemias may reflect more-intense parasit-
ized sequestration (eg, in the gut) and vital organ dysfunction 
[1] or, more specifically, host-phagocytic dysfunction resulting 
from the massive intravascular release of parasite cellular com-
ponents and malaria pigment. Salmonella infections (particularly 
nontyphoid Salmonella) have been associated specifically with 
falciparum malaria infections in African children [2, 3, 5, 8, 19]. 
In this study, one-third of the bacteremias were with S. Typhi and 
it is noteworthy that S. Typhi was also the most common cause 
of community-acquired bacteremia identified in Ho Chi Minh 
City during this period [20, 21]. Although empirical antibiotics 
are not indicated on admission in adults with severe malaria un-
less they have very high parasite counts, antibiotic treatment may 
well be needed subsequently in patients who deteriorate [1], as 
nosocomial bacterial infections are relatively common following 
admission in severely ill patients.
These results contrast markedly with a recent study from 
Myanmar in which 15% (13 of 87) of adults hospitalized with 
a primary diagnosis of malaria were bacteremic [16]. Malaria 
transmission in both countries is generally low and seasonal. 
However, the Myanmar patient characteristics were very dif-
ferent from those of the Vietnamese adults with strictly defined 
severe falciparum malaria. Only some of the Myanmar patients 
may have had severe malaria, semi-quantitative malaria parasite 
counts were generally low (and were significantly lower in bac-
teremic than in nonbacteremic patients), and many had neutro-
phil leukocytosis, all suggesting a primarily bacterial illness. The 
prevalence of bacteremia in the Myanmar adult patients was 23 
times higher than in the Vietnamese adults with strictly defined 
severe falciparum malaria and less than 20% parasitemia (15% 
vs 0.65%). Even in the 3 Myanmar fatal cases parasite counts 
were low (recorded as 1+ in 2 patients, and 2+ in 1 patient), 
whereas all the parasite counts of the Vietnam bacteremic pa-
tients would have scored 4+ in the semi-quantitative system—
and with quantitative counts, 4 had more than 20% parasitemia 
(of whom 3 died). The low overall mortality in the Myanmar 
series of 3.4% (3/87) was attributed to early use of antibiotics; 
yet, most of the Vietnamese patients did not receive antibiotics. 
It is therefore very unlikely that a high proportion of them had 
covert bacterial septicemia. The simplest and most probable ex-
planation for the marked difference between the 2 studies relates 
to the primary diagnosis. The Vietnam patients undoubtedly 
had severe falciparum malaria as their primary condition, with 
bacteremia occurring late in the course of their illness, whereas 
it is likely that the bacteremic Myanmar patients had bacterial 
sepsis as their primary condition, and their malaria parasitemia 
was incidental (ie, their fever and illness were caused by their 
bacterial infections and not malaria). This would explain the 
apparent high prevalence of bacteremia, their very low para-
site counts, and their neutrophil leukocytosis. Asymptomatic 
parasitemias are common in malaria-endemic areas. It is un-
derstandable that an ill febrile patient with a positive malaria 
smear would be considered to have malaria if there was no ob-
vious focus of bacterial infection. However, severe falciparum 
malaria results from a current or previous large sequestered 
parasite burden [1], whereas incidental parasitemia is associ-
ated with parasite burdens that are many orders of magnitude 
lower [22]. These 2 very different syndromes, requiring different 
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management, can be distinguished by quantitative malaria par-
asite counts and by other parasite burden indicators such as 
the proportions of neutrophils containing malaria pigment, 
the stage of malaria parasite development, and plasma concen-
trations of PfHRP2 or P. falciparum DNA [23–26]. As parasite 
counting, staging, and neutrophil pigment assessment can all 
be done rapidly on admission thin- and thick-film blood films, 
this emphasizes the value of experienced microscopy in the 
assessment of patients hospitalized with malaria. The interval 
from taking the blood smear to completing the thin-film par-
asite count can be as little as 5 minutes [27]. Semi-quantitative 
counts using the old “plus” or “cross” system are unreliable and 
are no longer recommended by the World Health Organization 
[28]. They are particularly unsuited for patients hospitalized 
with malaria, as the maximum semi-quantitative count of 4+ 
(>10 parasites in 1 thick blood film oil-immersion high-power 
field) encompasses parasitemias ranging from less than 1% to 
100%. Misdiagnosis also contributes significantly to the high 
rates of concomitant bacteremia and “severe” malaria reported 
in African children [25] and explains many of the apparent as-
sociations between both falciparum and vivax malaria and a 
variety of unrelated conditions. The high prevalence of asymp-
tomatic parasitemia in endemic areas means that many patients 
admitted to the hospital with other conditions will be labeled as 
having malaria. In a retrospective review of 400 adult patients 
with severe imported malaria admitted to 45 French intensive 
care units, 9 (2.3%) were bacteremic and 1 had candidemia on 
admission [29]. However, the patients in France were substan-
tially older (median age, 45 years) than the Vietnamese adults in 
this series, 7.3% of patients had immune deficiencies, and 14.3% 
had 1 or more comorbidities.
Although this study in Vietnamese adults was long, large, 
and detailed, it has several limitations. Empirical use of anti-
biotics before admission to the hospital is common in Asia (and 
was reported in 35% of the Myanmar series) and could have 
obscured some bacterial infections. However, prior antibiotic 
use was unusual in the low-income rural population at risk of 
malaria in Vietnam between 1991 and 2003, so is unlikely to 
be a significant confounder. Blood culture is intrinsically insen-
sitive, so bacteremia was probably underestimated. The target 
blood volume cultured (10 mL), which was the same in both the 
Myanmar and Vietnam series, is not maximally sensitive [30, 
31]. It is also noteworthy that 6 of the 9 positive blood cultures 
were obtained following the  change to an  automated blood 
culture system, so the earlier manual culture system may have 
been less sensitive. However, the Vietnamese patients with se-
vere malaria were not given routine antibiotics after admission, 
yet 87% survived, and most deaths were clearly attributable to 
severe falciparum malaria. It seems very unlikely that these var-
ious differences could account for the marked discrepancy be-
tween this and the Myanmar series, particularly as many of the 
Myanmar patients did not have strictly defined severe malaria.
High parasitemia was clearly a risk factor for concomitant 
bacteremia. Of the 76 patients with more than 20% parasitemia 
(9% of the total), 4 (5.2%) were also bacteremic. This group has 
a high mortality, so giving broad-spectrum antibiotics empir-
ically to patients with very high parasitemias is justified. Thin 
blood smear assessment should be performed on all patients 
admitted with severe falciparum malaria. Overall, however, in 
contrast to children in areas of higher malaria transmission, the 
incidence of concomitant bacteremia in adults with severe ma-
laria is low and does not warrant the use of empirical antibiotics 
in all patients.
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